Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Chalandon

Donor Lymphocyte Infusions Induce Durable Responses in Patients With Follicular, Mantle and T Cell Lymphomas Relapsing After an Allosct. An Ebmt-LWP Study

Hematological Oncology

English

How to Select Donor, Stem Cell Source, and Conditioning Regimen for Haploidentical Transplants With Post-Transplant Cyclophosphamide for Lymphoma: A Report of the Ebmt LWP

Hematological Oncology

English

Related publications

T-Cells in Follicular Hyperplasia and Follicular Center-Cell Lymphomas: An Immunoultrastructural Study of the T-Cell Receptor-Associated CD3 Antigen.

Journal of Histochemistry and Cytochemistry

Anatomy

Histology

1987

English

The Efficacy of Ibrutinib in Patients With Relapsed Mantle Cell Lymphoma After First Line Intensive Chemo-Immunotherapy and Asct - A Retrospective Study From the LWP-Ebmt

Hematological Oncology

English

Myeloablative T Cell-Depleted alloSCT With Early Sequential Prophylactic Donor Lymphocyte Infusion Is an Efficient and Safe Post-Remission Treatment for Adult ALL

Bone Marrow Transplantation

Transplantation

Hematology

2014

English

Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon

Clinical Lymphoma, Myeloma and Leukemia

English

Characterization of T Cell Repertoire in Patients With Graft-Versus-Leukemia After Donor Lymphocyte Infusion.

Journal of Clinical Investigation

Medicine

1997

English

Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case Report

Pediatric Blood and Cancer

English

Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Chronic Myelomonocytic Leukemia

Bone Marrow Transplantation

Transplantation

Hematology

2006

English

Individually Adjusted Prophylactic Donor Lymphocyte Infusions After CD34-selected Allogeneic Peripheral Blood Stem Cell Transplantation

Bone Marrow Transplantation

Transplantation

Hematology

2001

English

Molecular Remission Induced by Gemtuzumab Ozogamicin Associated With Donor Lymphocyte Infusions in T(4;11) Acute Lymphoblastic Leukemia Relapsed After Transplantation

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Y. Chalandon

Donor Lymphocyte Infusions Induce Durable Responses in Patients With Follicular, Mantle and T Cell Lymphomas Relapsing After an Allosct. An Ebmt-LWP Study

How to Select Donor, Stem Cell Source, and Conditioning Regimen for Haploidentical Transplants With Post-Transplant Cyclophosphamide for Lymphoma: A Report of the Ebmt LWP

Related publications

T-Cells in Follicular Hyperplasia and Follicular Center-Cell Lymphomas: An Immunoultrastructural Study of the T-Cell Receptor-Associated CD3 Antigen.

The Efficacy of Ibrutinib in Patients With Relapsed Mantle Cell Lymphoma After First Line Intensive Chemo-Immunotherapy and Asct - A Retrospective Study From the LWP-Ebmt

Myeloablative T Cell-Depleted alloSCT With Early Sequential Prophylactic Donor Lymphocyte Infusion Is an Efficient and Safe Post-Remission Treatment for Adult ALL

Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab, Bortezomib, Donor Lymphocytes, and Pegylated Interferon

Characterization of T Cell Repertoire in Patients With Graft-Versus-Leukemia After Donor Lymphocyte Infusion.

Persistent Multiyear Control of Relapsed T-Cell Acute Lymphoblastic Leukemia With Successive Donor Lymphocyte Infusions: A Case Report

Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Chronic Myelomonocytic Leukemia

Individually Adjusted Prophylactic Donor Lymphocyte Infusions After CD34-selected Allogeneic Peripheral Blood Stem Cell Transplantation

Molecular Remission Induced by Gemtuzumab Ozogamicin Associated With Donor Lymphocyte Infusions in T(4;11) Acute Lymphoblastic Leukemia Relapsed After Transplantation